In conclusion, we provide evidence for the first time that IL-37 was decreased in human NSCLC and inhibits lung tumorigenesis in vivo, possibly by inhibiting tumor angiogenesis. This evidence concerns the gene IL37 and non-small cell lung carcinoma.